Work

Comparing First-line Natalizumab and Ocrelizumab Use for the Treatment of Multiple Sclerosis: A Komodo Health Claims Database Study (P7-1.012)

Year: 2025

Type: article

Study design: Observational Study

Source: Neurology

DOI: 10.1212/wnl.0000000000211891

Authors: Jeffrey Kaplan, Dana Beenstock, Martin Belkin, Heidi Crayton, Christopher Eckstein, Ruth Fredericks, Boyang Bian, Nicholas Belviso, Daphne Ni, Danette Rutledge

Institutions: Michigan Institute for Neurological Disorders, Duke University, Biogen (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409226839

FWCI:

Cites:

Cited by:

Related to: 10